We are live on
!
Find out more
NVO
Novo Nordisk
NVO
NVO
1,270 hedge funds and large institutions have $12.4B invested in Novo Nordisk in 2026 Q1 according to their latest regulatory filings, with 148 funds opening new positions, 445 increasing their positions, 473 reducing their positions, and 270 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.31% more ownership
Funds ownership: 9.3% → 9.61% (+0.31%)
6% less repeat investments, than reductions
Existing positions increased: 445 | Existing positions reduced: 473
10% less funds holding
Funds holding: 1,413 → 1,270 (-143)
23% less capital invested
Capital invested by funds: $16.1B → $12.4B (-$3.75B)
33% less call options, than puts
Call options by funds: $1.44B | Put options by funds: $2.14B
45% less funds holding in top 10
Funds holding in top 10: 20 → 11 (-9)
45% less first-time investments, than exits
New positions opened: 148 | Existing positions closed: 270
Holders
1,270
Holders Change
-143
Holders Change %
-10.12%
% of All Funds
15.64%
Holding in Top 10
11
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-45%
% of All Funds
0.14%
New
148
Increased
445
Reduced
473
Closed
270
Calls
$1.44B
Puts
$2.14B
Net Calls
-$701M
Net Calls Change
+$511M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$411M |
| 2 |
Goldman Sachs
New York
|
-$278M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$248M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$245M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$221M |
